| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |